MSBC yields 1.99% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, MSBC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MSBC + ABBV for your $10,000?
Mission Bancorp operates as the bank holding company for Mission Bank that provides various banking products and services to individual and corporate clients in California. It accepts various checking and savings, NOW, money market, fiduciary, and individual retirement accounts, as well as time deposits and certificates of deposit. The company also provides commercial loans, such as lines of credit, equipment and vehicle financing, permanent working capital or debt refinance, commercial real estate loans, construction financing, and letters of credit; and agricultural loans, including operating/crop lines of credit, cattle loans, equipment loans, real estate loans, and loans for farmer. In addition, it offers SBA loans for owner-occupied commercial real estate purchase and construction, business expansion/acquisition, partner or management buy-out, equipment financing, debt refinance, inventory purchase, furniture, machinery, business startup cost, and working capital; and debit and credit cards. Further, the company provides safe deposit boxes, merchant card processing, online cash management, remote deposit capture, treasury management, and online and mobile banking services; cash vault services; and carries out property exchange transactions. It operates nine full-service facilities, including one located in Shafter, two located in Bakersfield, three located in the Mojave Desert area, one located in Ventura, one located in San Luis Obispo, and one located in Stockton. Mission Bancorp was founded in 1998 and is based in Bakersfield, California.
Full MSBC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.